Is Your Nervous System Out of Balance?

Take the Assessment →

Buying guide

Best vagus nerve stimulation device for sleep in 2026

Sleep is the one outcome in this category with a real meta-analysis behind it. That changes what a sensible ranking looks like.

The short answer

A 2025 meta-analysis of six trials in 336 patients found transcutaneous auricular stimulation improved sleep quality, with PSQI scores down 3.60 points. The reviewers graded that evidence low to very low.

For a routine you will keep, Pulsetto at $259, a four to twenty minute session you can run lying down. For the closest match to the trials, the Parasym ear clip sold as Nurosym or Nuropod, which is auricular and named in published methods.

Check the current Pulsetto price

Disclosure: Vagus Lab may earn a commission if you buy through links on this page. It does not change how we score devices. Our method is published and applied the same way to devices we have no commercial relationship with.

What the sleep evidence actually says

This is the section that should shape your purchase, so it goes before the list.

A systematic review and meta-analysis published in Neuromodulation in 2025 pooled six trials of transcutaneous auricular vagus nerve stimulation in insomnia, covering 336 patients. Sleep quality improved: Pittsburgh Sleep Quality Index scores fell by 3.60 points and insomnia severity by 5.24 against comparison.

Two caveats travel with that, and both matter for choosing a device.

The reviewers graded the evidence low to very low. Small samples, short durations, few well blinded trials. That is not evidence of no effect. It does mean the confident claims on product pages are ahead of the data.

The trials were auricular. They stimulated at the ear. Neck devices have not been tested for this outcome, which is different from having been tested and failed. Anyone telling you a neck device is proven for sleep is reading a paper that does not exist.

The five devices, ranked for sleep

Ranked for this outcome only. The order below is not our overall ranking, and the reason is explained under the list.

1. Pulsetto

$259

Best for an evening routine you will keep

Why it is here: Sessions of four to twenty minutes, worn rather than held, so you can run one lying in bed with the lights off. Sleep is where positive user reports cluster for this device, and the app carries dedicated sleep programs.

Watch out: No indexed publication names Pulsetto, and the insomnia trials used ear stimulation rather than the neck. Nothing runs without the phone app.

2. Nurosym, sold as Nuropod in the US

$900

Best match to the trial protocol

Why it is here: The insomnia meta-analysis pooled trials of auricular stimulation, and this is the auricular device named in published trial methods. No app, no subscription, CE certified as a medical device.

Watch out: Thirty to sixty minutes a day on a wired clip, which is a large ask at bedtime, and it is the most expensive device in the category.

3. Xen by Neuvana

$449

Best if you already fall asleep to audio

Why it is here: Ear stimulation synced to whatever you are listening to, fifteen minutes a day. If your wind down already involves a podcast or music, the session costs you nothing extra in time.

Watch out: No indexed study names Xen, and Neuvana does not publish battery or warranty figures. Earbuds in bed do not suit every sleeper.

4. Sensate

~$398

Best pure wind down ritual

Why it is here: You lie down, it rests on your sternum and hums along with a soundscape for ten to thirty minutes. It is the most reliably pleasant thing in this category, and 90 days risk free is the longest window to judge it in.

Watch out: Infrasonic rather than electrical, so the insomnia meta-analysis does not apply to it. Its own evidence is one uncontrolled pilot of 25 adults.

5. Apollo Neuro

$448

Best if you will not do a session at all

Why it is here: Runs in the background with nothing to schedule, and a study in JMIR mHealth and uHealth looked specifically at how long the device is worn and its association with sleep. Ships bundled with a sleep band.

Watch out: Vibrotactile, not vagus nerve stimulation, so none of the tVNS sleep evidence transfers. Six to ten hour battery means charging it before bed, not during.

Why this order is different from our overall ranking

On the hub we score devices across ten weighted criteria, where evidence carries a lot of weight. Here, two things move.

Adherence matters more for sleep than for anything else. A sleep intervention has to survive the moment you are already in bed and cannot be bothered. Every trial that found something ran daily for weeks, so a device that gets skipped is not a weaker version of the treatment, it is not the treatment.

Sensate rises and Apollo appears at all. Neither is electrical vagus nerve stimulation, so neither benefits from the insomnia meta-analysis. Both earn their place here on format: a wind down ritual and a device that needs no session respectively. That is a legitimate way to buy for sleep and a bad way to buy for evidence.

What to expect, and what not to

The realistic version: modest improvements in how you rate your own sleep, appearing over weeks of consistent use, in a literature the reviewers themselves call low quality. That is worth something. It is not a treatment for a sleep disorder, and none of these devices are cleared as one.

If you want a number to watch instead, be careful which one. A Bayesian meta-analysis of 16 studies found strong evidence that acute stimulation does not change heart rate variability in healthy people, and HRV is the metric most often waved around in this category. Our full read of the evidence covers where the claims hold and where they do not.

Frequently asked questions

It is the outcome with the best support in this field. A 2025 systematic review and meta-analysis of transcutaneous auricular stimulation in insomnia pooled six trials covering 336 patients and found sleep quality improved, with PSQI scores down 3.60 points and insomnia severity down 5.24 against comparison. The reviewers graded the quality of that evidence low to very low, so it is a real signal from a thin literature rather than a settled result.

Keep reading

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission. We do not pay for product placements, and we do not adjust scores based on commission rate. Our scoring methodology is published on this page.